{"id":"https://openalex.org/W2000101702","doi":"https://doi.org/10.1046/j.1365-2125.1997.00615.x","title":"Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non\u2010case study in the French pharmacovigilance system database","display_name":"Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non\u2010case study in the French pharmacovigilance system database","alternate_titles":[],"publication_year":1997,"publication_date":"1997-11-01","ids":{"openalex":"https://openalex.org/W2000101702","doi":"https://doi.org/10.1046/j.1365-2125.1997.00615.x","mag":"2000101702","pmid":"https://pubmed.ncbi.nlm.nih.gov/9384470","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2042872"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2125.1997.00615.x","doi":"https://doi.org/10.1046/j.1365-2125.1997.00615.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.1997.00615.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.1997.00615.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000101702"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.1997.00615.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Nicholas Moore","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nicholas Moore","raw_affiliation_strings":["French Pharmacovigilance System, Regional Pharmacovigilance Centre at Rouen, French Medicines Agency, Paris","Bordeaux, ,","Rouen, ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"French Pharmacovigilance System, Regional Pharmacovigilance Centre at Rouen, French Medicines Agency, Paris","institution_ids":[]},{"raw_affiliation_string":"Bordeaux, ,","institution_ids":[]},{"raw_affiliation_string":"Rouen, ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110079462","display_name":"Carmen Kreft-Ja\u00efs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carmen Kreft\u2010Jais","raw_affiliation_strings":["Broussais, ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broussais, ,","institution_ids":["https://openalex.org/I4210166329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030965793","display_name":"Fran\u00e7oise Haramburu","orcid":"https://orcid.org/0000-0001-5667-5195","observed_orcids":["https://orcid.org/0000-0001-5667-5195"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fran\u00e7oise Haramburu","raw_affiliation_strings":["Bordeaux, ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bordeaux, ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066296702","display_name":"C. Noblet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catherine Noblet","raw_affiliation_strings":["Rouen, ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rouen, ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113576087","display_name":"Michel Andr\u00e9jak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michel Andrejak","raw_affiliation_strings":["Amiens, ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amiens, ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044501271","display_name":"Michel Ollagnier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michel Ollagnier","raw_affiliation_strings":["French Association of Regional Pharmacovigilance Centres, With the assistance of all 31 Regional Centres of the French Pharmacovigilance System, and of the Pharmacovigilance unit, French Medicines Agency, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"French Association of Regional Pharmacovigilance Centres, With the assistance of all 31 Regional Centres of the French Pharmacovigilance System, and of the Pharmacovigilance unit, French Medicines Agency, Paris, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110016031","display_name":"Bernard B\u00e9gaud","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernard B\u00e9gaud","raw_affiliation_strings":["Bordeaux, ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bordeaux, ,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.0668,"has_fulltext":true,"cited_by_count":146,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.82204977,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"44","issue":"5","first_page":"513","last_page":"518"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9599999785423279},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8669999837875366},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.9490000009536743},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.6759999990463257},{"id":"https://openalex.org/keywords/cibenzoline","display_name":"cibenzoline","score":0.9150000214576721},{"id":"https://openalex.org/keywords/disopyramide","display_name":"disopyramide","score":0.8799999952316284},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.9350000023841858},{"id":"https://openalex.org/keywords/diltiazem","display_name":"diltiazem","score":0.9660000205039978},{"id":"https://openalex.org/keywords/nitrate","display_name":"nitrate","score":0.8989999890327454},{"id":"https://openalex.org/keywords/furosemide","display_name":"furosemide","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.7599999904632568},{"id":"https://openalex.org/keywords/spontaneous-reporting","display_name":"spontaneous reporting","score":0.7070000171661377},{"id":"https://openalex.org/keywords/arterial-disease","display_name":"arterial disease","score":0.6850000023841858},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.9879999756813049}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.9365657567977905},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6664081811904907},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.4761890470981598},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.473217636346817},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2613232135772705},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.15622681379318237}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1046/j.1365-2125.1997.00615.x","doi":"https://doi.org/10.1046/j.1365-2125.1997.00615.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.1997.00615.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.1997.00615.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2042872","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2042872/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:9384470","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9384470","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1046/j.1365-2125.1997.00615.x","doi":"https://doi.org/10.1046/j.1365-2125.1997.00615.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.1997.00615.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.1997.00615.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000101702.pdf","grobid_xml":"https://content.openalex.org/works/W2000101702.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2008875813","https://openalex.org/W2036266922","https://openalex.org/W2044979454","https://openalex.org/W2077814735","https://openalex.org/W2229524248","https://openalex.org/W2432190563","https://openalex.org/W4250050527"],"related_works":["https://openalex.org/W1988661239","https://openalex.org/W2504968350","https://openalex.org/W7162025774","https://openalex.org/W2068811933","https://openalex.org/W1965661114","https://openalex.org/W3158758468","https://openalex.org/W3185058623","https://openalex.org/W4255130722","https://openalex.org/W2049940834","https://openalex.org/W4251555753"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"test":[2],"the":[3,46,75,166,174],"existence":[4],"of":[5,10,51,77,87,168,176,202,212],"an":[6,30],"association":[7,31,62,175,199],"between":[8,32,63,200],"reports":[9,20,36,50,58,89,101],"hypoglycaemia":[11,52,70,91,112,179,203],"and":[12,39,55,69,136,156,184,204,235],"angiotensin":[13,40],"converting":[14,41],"enzyme":[15,42],"inhibitors,":[16],"in":[17,74,165,223],"a":[18],"spontaneous":[19],"database.":[21],"METHODS:":[22],"The":[23,61,188,198],"French":[24],"Pharmacovigilance":[25],"database":[26],"was":[27,71,190,207,216],"examined":[28],"for":[29,192,219],"adverse":[33],"drug":[34],"reaction":[35],"mentioning":[37],"hypoglycaemia,":[38],"inhibitors":[43,206],"(ACEI)":[44],"using":[45],"case/non-case":[47],"methodology,":[48],"with":[49,93,111,161,178],"as":[53,59,230],"cases":[54],"all":[56],"other":[57,66,157,193,220],"comparators.":[60],"ACEI":[64,103,155,177],"or":[65,80,146,150,171,226],"chosen":[67],"drugs":[68,109,158,194,221],"also":[72,218],"tested":[73],"subgroups":[76,167],"patients":[78,169],"taking":[79,170],"not":[81,142,172],"antidiabetic":[82,213],"agents":[83],"(ADA).":[84],"RESULTS:":[85],"428":[86],"93,338":[88],"mentioned":[90,102],"(202/2227":[92],"ADA":[94],"(OR":[95,104,115,119,123,127,133,138,181],"40,":[96],"95%":[97],"CI":[98],"33-48)).":[99],"46/5717":[100],"1.8":[105],"(1.25-2.54)).":[106],"Other":[107],"study":[108],"associated":[110,160],"were":[113,159],"cibenzoline":[114],"80":[116],"(57-112)),":[117],"disopyramide":[118],"32":[120],"(22-46)),":[121],"nifedipine":[122],"2.16":[124],"(1.32-3.51)),":[125],"diltiazem":[126],"1.76":[128],"(1.01-3.06))":[129],"nitrates":[130],"(nitroglycerin,":[131],"molsidomine)":[132],"1.91":[134],"(1.16-3.16))":[135],"frusemide":[137],"1.89":[139],"(1.31-1.76)),":[140],"but":[141],"nicardipine,":[143],"amlodipine,":[144],"felodipine":[145],"nitrendipine,":[147],"diazepam,":[148],"atenolol":[149],"combination":[151],"thiazide":[152],"diuretics.":[153],"However,":[154],"ADA,":[162,173],"so":[163],"that":[164],"disappeared":[180],"0.9":[182],"(0.5-1.4)":[183],"1.2":[185],"(0.7-2.2),":[186],"respectively).":[187],"same":[189],"found":[191],"except":[195],"cibenzoline.":[196],"CONCLUSION:":[197],"reporting":[201],"ACE":[205],"related":[208],"to":[209],"concomitant":[210],"use":[211],"agents.":[214],"This":[215],"true":[217],"used":[222],"arterial":[224],"disease":[225],"renal":[227],"failure,":[228],"such":[229],"calcium":[231],"channel":[232],"blockers,":[233],"nitrates,":[234],"frusemide.":[236]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000101702","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":8},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
